Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)‘s stock had its “buy” rating reissued by stock analysts at Bloom Burton in a research note issued on Friday. A number of other research analysts also recently issued reports on AUPH. HC Wainwright restated a “buy” rating and set a $10.00 target price on shares of Aurinia Pharmaceuticals in a research […]
